These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 38839638)

  • 1. Predictors associated with the rate of progression of nigrostriatal degeneration in Parkinson's disease.
    Yoo HS; Kim HK; Lee HS; Yoon SH; Na HK; Kang SW; Lee JH; Ryu YH; Lyoo CH
    J Neurol; 2024 Aug; 271(8):5213-5222. PubMed ID: 38839638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of striatal dopamine depletion on cognition in de novo Parkinson's disease.
    Chung SJ; Yoo HS; Oh JS; Kim JS; Ye BS; Sohn YH; Lee PH
    Parkinsonism Relat Disord; 2018 Jun; 51():43-48. PubMed ID: 29526657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nigrostriatal dopamine transporter availability, and its metabolic and clinical correlates in Parkinson's disease patients with impulse control disorders.
    Navalpotro-Gomez I; Dacosta-Aguayo R; Molinet-Dronda F; Martin-Bastida A; Botas-Peñin A; Jimenez-Urbieta H; Delgado-Alvarado M; Gago B; Quiroga-Varela A; Rodriguez-Oroz MC
    Eur J Nucl Med Mol Imaging; 2019 Sep; 46(10):2065-2076. PubMed ID: 31273436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo imaging of neuromelanin in Parkinson's disease using 18F-AV-1451 PET.
    Hansen AK; Knudsen K; Lillethorup TP; Landau AM; Parbo P; Fedorova T; Audrain H; Bender D; Østergaard K; Brooks DJ; Borghammer P
    Brain; 2016 Jul; 139(Pt 7):2039-49. PubMed ID: 27190023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal Change of DAT SPECT in Parkinson's Disease and Multiple System Atrophy.
    Sakakibara S; Hashimoto R; Katayama T; Kenjyo M; Yokokawa Y; Saito Y; Hirakawa A; Ito M; Nakamura T; Hara K; Hashizume A; Aiba I; Inukai A; Katsuno M
    J Parkinsons Dis; 2020; 10(1):123-130. PubMed ID: 31707374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pattern of FP-CIT PET in pure white matter hyperintensities-related vascular parkinsonism.
    Lee YH; Lee S; Chung SJ; Yoo HS; Jung JH; Baik K; Ye BS; Sohn YH; Yun M; Lee PH
    Parkinsonism Relat Disord; 2021 Jan; 82():1-6. PubMed ID: 33220520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nigrosome 1 visibility and its association with nigrostriatal dopaminergic loss in Parkinson's disease.
    Kim HK; Kim T; Baek MS; Kim EY; Sung YH; Lee JH; Ryu YH; Ahn SJ; Yoo HS; Lyoo CH
    Eur J Neurol; 2023 Jun; 30(6):1639-1647. PubMed ID: 36915220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study.
    Iranzo A; Valldeoriola F; Lomeña F; Molinuevo JL; Serradell M; Salamero M; Cot A; Ros D; Pavía J; Santamaria J; Tolosa E
    Lancet Neurol; 2011 Sep; 10(9):797-805. PubMed ID: 21802993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of the Non-Motor Burden with Patterns of Striatal Dopamine Loss in de novo Parkinson's Disease.
    Chung SJ; Lee S; Yoo HS; Lee YH; Lee HS; Choi Y; Lee PH; Yun M; Sohn YH
    J Parkinsons Dis; 2020; 10(4):1541-1549. PubMed ID: 32925098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [123I]FP-CIT SPECT in Clinically Uncertain Parkinsonism Predicts Survival: A Data-Driven Analysis.
    Frings L; Henninger F; Treppner M; Köber G; Boeker M; Hellwig S; Buchert R; Meyer PT
    J Parkinsons Dis; 2020; 10(4):1457-1465. PubMed ID: 33044193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of dopamine on response inhibition in Parkinson's disease relates to age-dependent patterns of nigrostriatal degeneration.
    Kübler D; Schroll H; Hamker FH; Joutsa J; Buchert R; Kühn AA
    Parkinsonism Relat Disord; 2019 Jun; 63():185-190. PubMed ID: 30765262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct FP-CIT PET patterns of Alzheimer's disease with parkinsonism and dementia with Lewy bodies.
    Chung SJ; Lee YH; Yoo HS; Sohn YH; Ye BS; Cha J; Lee PH
    Eur J Nucl Med Mol Imaging; 2019 Jul; 46(8):1652-1660. PubMed ID: 30980099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of association between dopamine transporter loss and non-motor symptoms in patients with Parkinson's disease: a detailed PET analysis of 12 striatal subregions.
    Park SB; Kwon KY; Lee JY; Im K; Sunwoo JS; Lee KB; Roh H; Ahn MY; Park S; Kim SJ; Oh JS; Kim JS
    Neurol Sci; 2019 Feb; 40(2):311-317. PubMed ID: 30415448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symmetric and Profound Monoaminergic Degeneration in Parkinson's Disease with Premotor REM Sleep Behavior Disorder.
    Woo KA; Kim HJ; Shin JH; Cho K; Choi H; Jeon B
    J Parkinsons Dis; 2024; 14(4):823-831. PubMed ID: 38640171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired finger dexterity and nigrostriatal dopamine loss in Parkinson's disease.
    Lee SH; Lee MJ; Lyoo CH; Cho H; Lee MS
    J Neural Transm (Vienna); 2018 Sep; 125(9):1333-1339. PubMed ID: 29971496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Striatal DAT and extrastriatal SERT binding in early-stage Parkinson's disease and dementia with Lewy bodies, compared with healthy controls: An
    Joling M; Vriend C; Raijmakers PGHM; van der Zande JJ; Lemstra AW; Berendse HW; Booij J; van den Heuvel OA
    Neuroimage Clin; 2019; 22():101755. PubMed ID: 30884365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early-onset drug-induced parkinsonism after exposure to offenders implies nigrostriatal dopaminergic dysfunction.
    Chung SJ; Yoo HS; Moon H; Oh JS; Kim JS; Park YH; Hong JY; Ye BS; Sohn YH; Lee PH
    J Neurol Neurosurg Psychiatry; 2018 Feb; 89(2):169-174. PubMed ID: 28912301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine transporter availability reflects gastrointestinal dysautonomia in early Parkinson disease.
    Hinkle JT; Perepezko K; Mills KA; Mari Z; Butala A; Dawson TM; Pantelyat A; Rosenthal LS; Pontone GM
    Parkinsonism Relat Disord; 2018 Oct; 55():8-14. PubMed ID: 30146185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Precise Evaluation of Striatal Oxidative Stress Corrected for Severity of Dopaminergic Neuronal Degeneration in Patients with Parkinson's Disease: A Study with 62Cu-ATSM PET and 123I-FP-CIT SPECT.
    Neishi H; Ikawa M; Okazawa H; Tsujikawa T; Arishima H; Kikuta KI; Yoneda M
    Eur Neurol; 2017; 78(3-4):161-168. PubMed ID: 28848099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in nigro-striatal impairment in clinical variants of early Parkinson's disease: evidence from a FP-CIT SPECT study.
    Rossi C; Frosini D; Volterrani D; De Feo P; Unti E; Nicoletti V; Kiferle L; Bonuccelli U; Ceravolo R
    Eur J Neurol; 2010 Apr; 17(4):626-30. PubMed ID: 20050904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.